Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1792742

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1792742

Nanopore Sequencing

PUBLISHED:
PAGES: 575 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Nanopore Sequencing Market to Reach US$968.6 Million by 2030

The global market for Nanopore Sequencing estimated at US$378.8 Million in the year 2024, is expected to reach US$968.6 Million by 2030, growing at a CAGR of 16.9% over the analysis period 2024-2030. Consumables Offering, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach US$624.2 Million by the end of the analysis period. Growth in the Instruments Offering segment is estimated at 19.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$103.2 Million While China is Forecast to Grow at 22.1% CAGR

The Nanopore Sequencing market in the U.S. is estimated at US$103.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$211.2 Million by the year 2030 trailing a CAGR of 22.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.7% and 15.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.5% CAGR.

Global Nanopore Sequencing Market - Key Trends & Drivers Summarized

Why Is Nanopore Sequencing Reshaping DNA and RNA Analysis?

Nanopore sequencing is gaining attention as a fast, portable, and scalable method for analyzing DNA and RNA molecules in real time. Unlike traditional sequencing platforms, nanopore technology detects nucleotide sequences by measuring changes in electrical current as a nucleic acid strand passes through a nanopore. This approach does not require amplification or labeling, which simplifies sample preparation and speeds up results. As a result, it has emerged as a valuable tool for on-site genetic testing, infectious disease surveillance, environmental monitoring, and clinical research.

Its ability to deliver long-read sequencing data in real time makes it especially useful for identifying complex structural variations, haplotype phasing, and full-length transcript analysis. Researchers are increasingly adopting nanopore sequencing to map entire genomes, detect epigenetic modifications, and study rare or hard-to-sequence organisms. The compact design and portability of nanopore devices allow for decentralized genomic analysis outside laboratory settings, broadening access and use in field research, diagnostics, and outbreak response.

How Are Technology Developments Enhancing Accuracy and Utility?

Recent advances in pore chemistry, motor proteins, and basecalling algorithms have improved the accuracy and throughput of nanopore sequencing systems. Enhanced nanopore materials provide more consistent signal patterns and longer reading durations. Updated enzymes that control the translocation speed of nucleic acids through the nanopore offer better resolution and read quality. At the software level, machine learning-based basecalling tools continue to reduce error rates and enable detection of single-nucleotide variants and methylation marks.

Integration with cloud-based platforms supports large-scale data processing, remote access, and collaborative analysis. Improvements in flow cell design and multiplexing capabilities allow researchers to sequence more samples per run at lower cost. Modular sequencing kits now accommodate a wide range of inputs, including degraded samples, metagenomic mixtures, or direct RNA strands, without the need for complex pre-processing. These improvements are making the technology more versatile and user-friendly for a broader research audience.

Which Sectors and Use Cases Are Driving Adoption of Nanopore Sequencing?

Academic research institutions remain early adopters of nanopore sequencing due to its utility in genomics, epigenetics, microbiology, and evolutionary studies. Clinical laboratories use it for rapid pathogen identification, antimicrobial resistance profiling, and genetic disease screening. In oncology, it supports tumor profiling, fusion gene detection, and transcriptomic analysis. The agricultural sector leverages the technology for crop genome analysis, soil microbiome profiling, and animal health monitoring.

Field-based applications are a key growth area. Public health agencies deploy nanopore platforms for real-time outbreak monitoring, including pathogen tracking in low-resource or remote settings. Wildlife researchers and conservationists use it for biodiversity studies and species identification. As costs decline and user interfaces become more accessible, small laboratories and point-of-care settings are exploring nanopore-based tools for decentralized testing and early diagnostics.

Growth in the Nanopore Sequencing Market Is Driven by Several Factors…

Growth in the nanopore sequencing market is driven by several factors. Demand for rapid, real-time, and long-read sequencing technologies supports continued adoption across research and clinical sectors. Advances in basecalling accuracy, enzyme chemistry, and signal processing enhance reliability and broaden utility. Expansion of low-cost, portable sequencing devices encourages use in remote, mobile, and decentralized environments. Growing interest in personalized medicine, infectious disease surveillance, and direct RNA sequencing further accelerates application development. Integration with bioinformatics platforms and cloud services facilitates efficient data analysis and sharing. Investments from academic institutions, healthcare systems, and governments contribute to expanding adoption and innovation pipelines.

SCOPE OF STUDY:

The report analyzes the Nanopore Sequencing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Consumables Offering, Instruments Offering); Sequencing Type (Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique, Exonuclease); Nanopore Type (Solid State Nanopore, Biological Nanopore, Hybrid Nanopore); Application (Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application, Other Applications); End-Use (Biotechnology Companies End-Use, Clinical Laboratories End-Use, Academic & Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Agilent Technologies, Inc.
  • BGI Genomics Co., Ltd.
  • CD-Genomics
  • Electronic Biosciences, Inc.
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • Genia Technologies (Roche subsidiary)
  • Illumina, Inc.
  • INanoBio Inc.
  • Nanopore Technologies plc (Oxford)
  • Nabsys, Inc.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Stratos Genomics, Inc.
  • Thermo Fisher Scientific Inc.
  • 10x Genomics, Inc.
  • Agilent Technologies, Inc.
  • Eurofins Scientific
  • Danaher Corporation (Beckman Coulter)
  • Myriad Genetics, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP37479

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Nanopore Sequencing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Real-Time and Portable Genomic Sequencing Drives Adoption of Nanopore Technology
    • Ability to Directly Read Long DNA and RNA Strands Throws Spotlight on Nanopore Unique Technical Advantage
    • Rise in Infectious Disease Surveillance and Variant Tracking Fuels Application in Pathogen Genomics
    • Rapid Turnaround Time and Minimal Sample Preparation Promote Use in Clinical and Field Settings
    • Expansion of Precision Medicine and Genetic Diagnostics Strengthens Business Case for On-Site Sequencing
    • OEM Investment in Miniaturized and Scalable Sequencing Devices Enhances Accessibility Across Use Cases
    • Advancements in Base Calling Accuracy and Error Correction Support Broader Scientific Acceptance
    • Growth in Agricultural Genomics and Environmental DNA Monitoring Boosts Utility in Non-Clinical Markets
    • Open Data Platforms and User-Driven Bioinformatics Tools Promote Community Engagement in Nanopore Research
    • Integration With AI-Based Analytics Enhances Interpretation of Complex Genomic Datasets
    • Surge in Cancer Genomics and Liquid Biopsy Research Encourages High-Resolution Sequencing Tools
    • Portability of Nanopore Devices Enables Sequencing in Remote, Resource-Limited, and Emergency Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nanopore Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nanopore Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Consumables Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Consumables Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Instruments Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Instruments Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Human Genetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Human Genetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Human Genetics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Clinical Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Clinical Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Clinical Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Plant Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Plant Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Plant Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Microbiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Microbiology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Microbiology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Biotechnology Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Clinical Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Direct Current by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Direct Current by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Direct Current by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Synthetic DNA & Horizontal Tunneling Current by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Synthetic DNA & Horizontal Tunneling Current by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Synthetic DNA & Horizontal Tunneling Current by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Optical Reading Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Optical Reading Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Optical Reading Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Exonuclease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Exonuclease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Exonuclease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Solid State Nanopore by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Solid State Nanopore by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: World 16-Year Perspective for Solid State Nanopore by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Biological Nanopore by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Biological Nanopore by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: World 16-Year Perspective for Biological Nanopore by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Hybrid Nanopore by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Hybrid Nanopore by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: World 16-Year Perspective for Hybrid Nanopore by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 56: USA Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: USA 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: USA 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: USA 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: USA 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 68: USA Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: USA Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: USA 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Canada 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Canada 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Canada 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 80: Canada Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Canada Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Canada 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 83: Canada Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Canada Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Canada 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • JAPAN
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Japan 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Japan 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 92: Japan Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Japan Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Japan 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 95: Japan Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Japan Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Japan 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 98: Japan Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Japan Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Japan 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • CHINA
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 101: China Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: China 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 104: China Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: China Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: China 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 107: China Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: China Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: China 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 110: China Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: China Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: China 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 113: China Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: China Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: China 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • EUROPE
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Nanopore Sequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Europe 16-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 119: Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Europe Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Europe 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 122: Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Europe Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Europe 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 125: Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Europe Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Europe 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 128: Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Europe Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Europe 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 131: Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Europe Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Europe 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • FRANCE
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 134: France Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: France Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: France 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 137: France Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: France Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: France 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 140: France Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: France Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: France 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 143: France Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: France Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: France 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 146: France Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: France Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: France 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • GERMANY
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 149: Germany Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Germany Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Germany 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 152: Germany Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Germany Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Germany 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 155: Germany Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Germany Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Germany 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 158: Germany Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Germany Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Germany 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 161: Germany Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Germany Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Germany 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 164: Italy Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Italy Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Italy 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 167: Italy Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Italy Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Italy 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 170: Italy Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Italy Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Italy 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 173: Italy Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Italy Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Italy 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 176: Italy Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Italy Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Italy 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 179: UK Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: UK Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: UK 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 182: UK Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: UK Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: UK 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 185: UK Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UK Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: UK 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 188: UK Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UK Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: UK 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 191: UK Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UK Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UK 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 194: Spain Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Spain Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Spain 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 197: Spain Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Spain Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Spain 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 200: Spain Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Spain Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Spain 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 203: Spain Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Spain Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Spain 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 206: Spain Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Spain Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Spain 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 209: Russia Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Russia Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Russia 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 212: Russia Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Russia Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Russia 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 215: Russia Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Russia Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Russia 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 218: Russia Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Russia Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Russia 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 221: Russia Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Russia Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Russia 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 224: Rest of Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Europe Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Rest of Europe 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 227: Rest of Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Europe Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Rest of Europe 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 230: Rest of Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Europe Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Rest of Europe 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 233: Rest of Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Europe Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Rest of Europe 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 236: Rest of Europe Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Europe Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Rest of Europe 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 239: Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 240: Asia-Pacific Historic Review for Nanopore Sequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 242: Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Asia-Pacific Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 245: Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Asia-Pacific Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 248: Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Asia-Pacific Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: Asia-Pacific 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 251: Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Asia-Pacific Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Asia-Pacific Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 257: Australia Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Australia Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Australia 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 260: Australia Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Australia Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Australia 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 263: Australia Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Australia Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Australia 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 266: Australia Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Australia Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Australia 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 269: Australia Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Australia Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Australia 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • INDIA
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 272: India Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: India Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: India 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 275: India Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: India Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: India 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 278: India Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: India Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: India 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 281: India Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: India Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: India 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 284: India Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: India Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: India 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 287: South Korea Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: South Korea Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: South Korea 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 290: South Korea Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: South Korea Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: South Korea 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 293: South Korea Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: South Korea Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: South Korea 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 296: South Korea Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: South Korea Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: South Korea 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 299: South Korea Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: South Korea Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: South Korea 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 302: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Asia-Pacific Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 305: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Asia-Pacific Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 307: Rest of Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 308: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Asia-Pacific Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 310: Rest of Asia-Pacific 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 311: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Asia-Pacific Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 313: Rest of Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 314: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Rest of Asia-Pacific Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 316: Rest of Asia-Pacific 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 317: Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 318: Latin America Historic Review for Nanopore Sequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 319: Latin America 16-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 320: Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Latin America Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 322: Latin America 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 323: Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Latin America Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 325: Latin America 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 326: Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Latin America Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 328: Latin America 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 329: Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Latin America Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 331: Latin America 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 332: Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Latin America Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 334: Latin America 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 335: Argentina Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Argentina Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 337: Argentina 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 338: Argentina Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Argentina Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 340: Argentina 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 341: Argentina Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Argentina Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 343: Argentina 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 344: Argentina Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Argentina Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 346: Argentina 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 347: Argentina Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Argentina Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 349: Argentina 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 350: Brazil Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Brazil Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 352: Brazil 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 353: Brazil Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Brazil Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 355: Brazil 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 356: Brazil Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Brazil Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 358: Brazil 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 359: Brazil Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Brazil Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 361: Brazil 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 362: Brazil Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Brazil Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 364: Brazil 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 365: Mexico Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Mexico Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 367: Mexico 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 368: Mexico Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Mexico Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 370: Mexico 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 371: Mexico Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Mexico Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 373: Mexico 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 374: Mexico Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Mexico Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 376: Mexico 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 377: Mexico Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Mexico Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 379: Mexico 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 380: Rest of Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Latin America Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 382: Rest of Latin America 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 383: Rest of Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Rest of Latin America Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 385: Rest of Latin America 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 386: Rest of Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Rest of Latin America Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 388: Rest of Latin America 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 389: Rest of Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Rest of Latin America Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 391: Rest of Latin America 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 392: Rest of Latin America Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Latin America Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 394: Rest of Latin America 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 395: Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 396: Middle East Historic Review for Nanopore Sequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 397: Middle East 16-Year Perspective for Nanopore Sequencing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 398: Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Middle East Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 400: Middle East 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 401: Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Middle East Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 403: Middle East 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 404: Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Middle East Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 406: Middle East 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 407: Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Middle East Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 409: Middle East 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 410: Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Middle East Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 412: Middle East 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 413: Iran Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Iran Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 415: Iran 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 416: Iran Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 417: Iran Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 418: Iran 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 419: Iran Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 420: Iran Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 421: Iran 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 422: Iran Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 423: Iran Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 424: Iran 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 425: Iran Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 426: Iran Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 427: Iran 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 428: Israel Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 429: Israel Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 430: Israel 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 431: Israel Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 432: Israel Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 433: Israel 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 434: Israel Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 435: Israel Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 436: Israel 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 437: Israel Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 438: Israel Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 439: Israel 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 440: Israel Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 441: Israel Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 442: Israel 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 443: Saudi Arabia Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 444: Saudi Arabia Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 445: Saudi Arabia 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 446: Saudi Arabia Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 447: Saudi Arabia Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 448: Saudi Arabia 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 449: Saudi Arabia Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 450: Saudi Arabia Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 451: Saudi Arabia 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 452: Saudi Arabia Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 453: Saudi Arabia Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 454: Saudi Arabia 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 455: Saudi Arabia Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 456: Saudi Arabia Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 457: Saudi Arabia 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 458: UAE Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 459: UAE Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 460: UAE 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 461: UAE Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 462: UAE Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 463: UAE 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 464: UAE Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 465: UAE Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 466: UAE 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 467: UAE Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 468: UAE Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 469: UAE 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 470: UAE Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 471: UAE Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 472: UAE 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 473: Rest of Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 474: Rest of Middle East Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 475: Rest of Middle East 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 476: Rest of Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 477: Rest of Middle East Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 478: Rest of Middle East 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 479: Rest of Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 480: Rest of Middle East Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 481: Rest of Middle East 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 482: Rest of Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 483: Rest of Middle East Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 484: Rest of Middle East 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 485: Rest of Middle East Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 486: Rest of Middle East Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 487: Rest of Middle East 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030
  • AFRICA
    • Nanopore Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 488: Africa Recent Past, Current & Future Analysis for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 489: Africa Historic Review for Nanopore Sequencing by Offering - Consumables Offering and Instruments Offering Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 490: Africa 16-Year Perspective for Nanopore Sequencing by Offering - Percentage Breakdown of Value Sales for Consumables Offering and Instruments Offering for the Years 2014, 2025 & 2030
    • TABLE 491: Africa Recent Past, Current & Future Analysis for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 492: Africa Historic Review for Nanopore Sequencing by Application - Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 493: Africa 16-Year Perspective for Nanopore Sequencing by Application - Percentage Breakdown of Value Sales for Human Genetics Application, Clinical Research Application, Plant Research Application, Microbiology Application and Other Applications for the Years 2014, 2025 & 2030
    • TABLE 494: Africa Recent Past, Current & Future Analysis for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 495: Africa Historic Review for Nanopore Sequencing by End-Use - Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 496: Africa 16-Year Perspective for Nanopore Sequencing by End-Use - Percentage Breakdown of Value Sales for Biotechnology Companies End-Use, Clinical Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2014, 2025 & 2030
    • TABLE 497: Africa Recent Past, Current & Future Analysis for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 498: Africa Historic Review for Nanopore Sequencing by Sequencing Type - Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 499: Africa 16-Year Perspective for Nanopore Sequencing by Sequencing Type - Percentage Breakdown of Value Sales for Direct Current, Synthetic DNA & Horizontal Tunneling Current, Optical Reading Technique and Exonuclease for the Years 2014, 2025 & 2030
    • TABLE 500: Africa Recent Past, Current & Future Analysis for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 501: Africa Historic Review for Nanopore Sequencing by Nanopore Type - Solid State Nanopore, Biological Nanopore and Hybrid Nanopore Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 502: Africa 16-Year Perspective for Nanopore Sequencing by Nanopore Type - Percentage Breakdown of Value Sales for Solid State Nanopore, Biological Nanopore and Hybrid Nanopore for the Years 2014, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!